Javascript must be enabled to continue!
TB-related catastrophic costs in Ethiopia
View through CrossRef
<sec><title>OBJECTIVES</title>To measure the progress towards reducing TB-related catastrophic costs in 19 zones of Amhara, Oromia, SNNP (Southern Nations and Nationalities, and Peoples) and Sidama Regions of Ethiopia.</sec><sec><title>METHODS</title>A
baseline survey was conducted in randomly selected health facilities from all districts within the 19 zones from November 2020 to February 2021. Interventions targeting the major drivers of catastrophic costs identified in the baseline survey, such as installation of 126 GeneXpert and 13 Truenat
machines, securing connectivity of 372 GeneXpert, establishing alternative specimen referral systems, and capacity-building of health workers, were implemented. A follow-up survey was conducted from October to December 2022. The WHO generic tool was used to collect data based on probability
proportional to size. Data were entered into STATA software, and the proportion of catastrophic costs was calculated and compared between the two surveys.</sec><sec><title>RESULTS</title>A total of 433 and 397 patients participated in the baseline and follow-up
surveys, respectively. The proportion of catastrophic costs reduced from 64.7% to 43.8% (P < 0.0001). The share of direct non-medical costs decreased from 76.2% to 19.2%, while medical and indirect costs increased from 11.6% and 12.3% to 30.4% and 52.4 %.</sec><sec><title>CONCLUSION</title>The
proportion of households facing TB-related catastrophic costs has significantly reduced over the 2-year period. However, it remains unacceptably high and varies among regions. Further reducing the catastrophic costs requires multisectoral response, reviewing the TB service exemption policy,
further decentralisation and improving the quality of TB services.</sec>
International Union Against Tuberculosis and Lung Disease
Title: TB-related catastrophic costs in Ethiopia
Description:
<sec><title>OBJECTIVES</title>To measure the progress towards reducing TB-related catastrophic costs in 19 zones of Amhara, Oromia, SNNP (Southern Nations and Nationalities, and Peoples) and Sidama Regions of Ethiopia.
</sec><sec><title>METHODS</title>A
baseline survey was conducted in randomly selected health facilities from all districts within the 19 zones from November 2020 to February 2021.
Interventions targeting the major drivers of catastrophic costs identified in the baseline survey, such as installation of 126 GeneXpert and 13 Truenat
machines, securing connectivity of 372 GeneXpert, establishing alternative specimen referral systems, and capacity-building of health workers, were implemented.
A follow-up survey was conducted from October to December 2022.
The WHO generic tool was used to collect data based on probability
proportional to size.
Data were entered into STATA software, and the proportion of catastrophic costs was calculated and compared between the two surveys.
</sec><sec><title>RESULTS</title>A total of 433 and 397 patients participated in the baseline and follow-up
surveys, respectively.
The proportion of catastrophic costs reduced from 64.
7% to 43.
8% (P < 0.
0001).
The share of direct non-medical costs decreased from 76.
2% to 19.
2%, while medical and indirect costs increased from 11.
6% and 12.
3% to 30.
4% and 52.
4 %.
</sec><sec><title>CONCLUSION</title>The
proportion of households facing TB-related catastrophic costs has significantly reduced over the 2-year period.
However, it remains unacceptably high and varies among regions.
Further reducing the catastrophic costs requires multisectoral response, reviewing the TB service exemption policy,
further decentralisation and improving the quality of TB services.
</sec>.
Related Results
Measuring Catastrophic Costs Due to Tuberculosis in Myanmar
Measuring Catastrophic Costs Due to Tuberculosis in Myanmar
Background: This is the first survey to use the World Health Organization (WHO) methodology to document the magnitude and main drivers of tuberculosis (TB) patient costs in order t...
Healthcare Utilization and Imputed Costs of Acute Myeloid Leukemia Patients By FLT3 Status and Early Midostaurin Use at a Comprehensive Cancer Center
Healthcare Utilization and Imputed Costs of Acute Myeloid Leukemia Patients By FLT3 Status and Early Midostaurin Use at a Comprehensive Cancer Center
Abstract
INTRODUCTION: Mutation of FLT3, a tyrosine kinase receptor, is one of the most common molecular alterations in AML. In 2017, the FDA approved midostaurin fo...
Costs, catastrophic out-of-pocket payments and impoverishment related to accessing surgical care among households in rural Ethiopia
Costs, catastrophic out-of-pocket payments and impoverishment related to accessing surgical care among households in rural Ethiopia
Abstract
Background
The objective of this study was to assess the costs, catastrophic out-of-pocket (OOP) health expenditure, i...
The Global Burden of Multidrug-Resistant Tuberculosis: An In-Depth Review of Catastrophic Costs, Patient Burdens, and Strategies for Sustainable Healthcare Solutions
The Global Burden of Multidrug-Resistant Tuberculosis: An In-Depth Review of Catastrophic Costs, Patient Burdens, and Strategies for Sustainable Healthcare Solutions
Background: Multidrug-resistant tuberculosis (MDR-TB) poses a significant global health challenge, with approximately 500,000 new cases reported in 2020, predominantly among vulner...
Out‐of‐Pocket Surgical Costs and Catastrophic Health Expenditure in Ethiopia: Results From a Nationwide Multicenter Cross‐Sectional Study
Out‐of‐Pocket Surgical Costs and Catastrophic Health Expenditure in Ethiopia: Results From a Nationwide Multicenter Cross‐Sectional Study
ABSTRACT
Introduction
Globally, over 4.8 billion people lack access to safe, timely, and affordable surgical care, with t...
Catastrophic health care payment in Myanmar : a case study in Upper Myanmar
Catastrophic health care payment in Myanmar : a case study in Upper Myanmar
Out-of-Pocket (OOP) payments are the principal means of financing health care throughout much of Asia. It leaves households exposed to the risk of unforeseen expenditures that abso...
Economic Burden of Sickle Cell Disease among Children and Adults.
Economic Burden of Sickle Cell Disease among Children and Adults.
Abstract
Background: The economic burden of sickle cell disease (SCD) has not been determined. Cost-of-care estimates improve health care planning, inform research p...
ANALISIS BIAYA TRANSAKSI USAHATANI PADI DI KECAMATAN BANGKINANG KABUPATEN KAMPAR
ANALISIS BIAYA TRANSAKSI USAHATANI PADI DI KECAMATAN BANGKINANG KABUPATEN KAMPAR
The rice plant is one of the agricultural products and is a major food for almost all the people of Indonesia. Farming capital is the production cost that will be spent by farmers ...

